Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Return on Sales (2016 - 2025)

Amphastar Pharmaceuticals (AMPH) has 13 years of Return on Sales data on record, last reported at 0.13% in Q4 2025.

  • For Q4 2025, Return on Sales fell 36.0% year-over-year to 0.13%; the TTM value through Dec 2025 reached 0.13%, down 35.0%, while the annual FY2024 figure was 0.23%, 1.0% up from the prior year.
  • Return on Sales reached 0.13% in Q4 2025 per AMPH's latest filing, down from 0.09% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.38% in Q2 2025 and bottomed at 4.02% in Q1 2025.
  • Average Return on Sales over 5 years is 0.03%, with a median of 0.19% recorded in 2023.
  • Peak YoY movement for Return on Sales: grew 23bps in 2021, then crashed -428bps in 2025.
  • A 5-year view of Return on Sales shows it stood at 0.17% in 2021, then soared by 102bps to 0.33% in 2022, then plummeted by -44bps to 0.19% in 2023, then grew by 24bps to 0.23% in 2024, then plummeted by -154bps to 0.13% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Sales were 0.13% in Q4 2025, 0.09% in Q3 2025, and 0.38% in Q2 2025.